Company Filing History:
1 out of 43 
1 out of 116 
Years Active: 2025
Title: Francesca Borgna: Innovator in Radiopeptide Technology
Introduction
Francesca Borgna is a prominent inventor based in Windisch, Switzerland. She has made significant contributions to the field of radiopeptide technology, particularly in the treatment of tumor diseases. Her innovative work has garnered attention in the scientific community.
Latest Patents
Francesca holds a patent for a radiopeptide that comprises a radionuclide, specifically terbium-161, a chelator coordinating terbium-161, and a peptide or peptide analogue that acts as a somatostatin receptor antagonist. This radiopeptide is designed for use in the treatment of tumor diseases, showcasing her commitment to advancing medical technology. She has 1 patent to her name.
Career Highlights
Throughout her career, Francesca has worked with esteemed institutions such as Universität Basel and Paul Scherrer Institut. Her research has focused on developing innovative solutions in the medical field, particularly in oncology.
Collaborations
Francesca has collaborated with notable colleagues, including Cristina Müller and Roger Schibli. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Francesca Borgna is a trailblazer in the field of radiopeptide technology, with a focus on improving treatment options for tumor diseases. Her work exemplifies the impact of innovation in medicine.